Cell Growth & Differentiation, Vol 6, Issue 11 1427-1435, Copyright © 1995 by American Association of Cancer Research

ARTICLES

Mitogenic signaling by transfected neuromedin B receptors in Rat-1 cells

EB Lach, S Broad and E Rozengurt
Imperial Cancer Research Fund, London, United Kingdom.

The rat neuromedin B (NMB) receptor was expressed in Rat-1 fibroblasts to elucidate the signaling pathways and mitogenic effects mediated by this seven-transmembrane domain receptor. Receptor expression was verified by ligand binding and Ca2+ mobilization, which were blocked by the NMB receptor antagonist D-Nal-Cys-Tyr-D-Trp-Orn-Val-Cys-Nal-NH2. NMB acted as a potent growth factor promoting DNA synthesis and cell proliferation in serum-free medium in Rat-1 cells transfected with the NMB receptor. Prior to DNA synthesis, NMB stimulated phosphorylation of 80K/MARCKS, a major substrate of protein kinase C, which could be prevented by the selective protein kinase C inhibitor GF 109203X. Furthermore, NMB induced a rapid p42MAPK activation and tyrosine phosphorylation of multiple proteins including p125FAK and paxillin. The half-maximal concentrations (EC50) of NMB required to induce DNA synthesis (0.7-0.9 nM) and cell proliferation (0.7-1 nM) paralleled the Kd for 125I-[D-Tyr0]NMB binding and the EC50 values for the induction of the early signaling events. Thus, NMB can activate multiple signal transduction pathways and act as a sole mitogen through its receptor expressed in Rat-1 fibroblasts.

This article has been cited by other articles:

				R. T. Jensen, J. F. Battey, E. R. Spindel, and R. V. Benya International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States Pharmacol. Rev., March 1, 2008; 60(1): 1 - 42. [Abstract] [Full Text] [PDF]

				R. R. Ryan, H. C. Weber, S. A. Mantey, W. Hou, M. E. Hilburger, T. K. Pradhan, D. H. Coy, and R. T. Jensen Pharmacology and Intracellular Signaling Mechanisms of the Native Human Orphan Receptor BRS-3 in Lung Cancer Cells J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 366 - 380. [Abstract] [Full Text]

				J. L. Rodriguez-Fernandez and E. Rozengurt Bombesin, Vasopressin, Lysophosphatidic Acid, and Sphingosylphosphorylcholine Induce Focal Adhesion Kinase Activation in Intact Swiss 3T3 Cells J. Biol. Chem., July 24, 1998; 273(30): 19321 - 19328. [Abstract] [Full Text] [PDF]

				E. Sainz, M. Akeson, S. A. Mantey, R. T. Jensen, and J. F. Battey Four Amino Acid Residues Are Critical for High Affinity Binding of Neuromedin B to the Neuromedin B Receptor J. Biol. Chem., June 26, 1998; 273(26): 15927 - 15932. [Abstract] [Full Text] [PDF]

				L. K. Needham and E. Rozengurt Galpha 12 and Galpha 13 Stimulate Rho-dependent Tyrosine Phosphorylation of Focal Adhesion Kinase, Paxillin, and p130 Crk-associated Substrate J. Biol. Chem., June 5, 1998; 273(23): 14626 - 14632. [Abstract] [Full Text] [PDF]

				R. R. Ryan, H. C. Weber, W. Hou, E. Sainz, S. A. Mantey, J. F. Battey, D. H. Coy, and R. T. Jensen Ability of Various Bombesin Receptor Agonists and Antagonists to Alter Intracellular Signaling of the Human Orphan Receptor BRS-3 J. Biol. Chem., May 29, 1998; 273(22): 13613 - 13624. [Abstract] [Full Text] [PDF]